FDA expands use of Organon’s contraception implant up to 5 years
Organon’s Nexplanon implant for preventing unwanted pregnancy can now be used for up to five years after the company gained …
Post
-
-
JPM26: Ypsomed commits to self-care delivery devices in new strategic plan
Ypsomed, a medical device company with a focus on self-care solutions, has announced a continued focus on delivery systems such …
-
Podcast: JPM26’s dealmaking falls short of expectations
This year's J.P. Morgan Healthcare Conference wrapped up without the usual high level of M&A we've grown accustomed to. Boston …
-
JPM26: Medtech VC sees kidney care entering new era of innovation
A medtech VC firm said kidney care is emerging as a key focus area, citing a range of startups innovating …
-
Epiminder conducts first US implant of Minder epilepsy monitoring system
Epiminder has announced the first implantation of its Minder System in the US, a device developed for ongoing monitoring of …
-
Zylox-Tonbridge to acquire German medical technology company Optimed
Zylox-Tonbridge, a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology …
-
iotaMotion gains paediatric FDA indication for cochlear implant robot
Robotics company iotaMotion has received a paediatric indication expansion for its robotic-assisted iotaSOFT cochlear implant insertion system from the US …
-
JPM26: Medtech CEO says conference’s appeal in decline
As the curtain falls on the 44th edition of the J.P. Morgan Healthcare Conference in San Francisco, a medtech company …
-
VB Spine to acquire Robotron’s SpineHawk spinal visualisation platform
US-based medical technology company VB Spine has agreed to acquire the SpineHawk intraoperative spinal visualisation platform from Robotron Surgical Technologies. The …
-
BD secures FDA 510(k) clearance for EnCor EnCompass system
BD (Becton, Dickinson and Company) has received 510(k) approval from the US Food and Drug Administration (FDA) for the EnCor …
-
JPM26: Opus Genetics builds momentum in rare retinal gene therapy
Inherited retinal diseases encompass more than 350 genetic mutations and represent a significant unmet clinical need. Opus Genetics’ portfolio approach …
-
JPM26: Butterfly Network aims to close the global medical imaging gap
Butterfly Network currently boasts the world’s largest installed base of point-of-care ultrasound (POCUS) devices, with its technology being utilised globally, …
-
JPM26: Rakuten Medical unveils transformative photoimmunotherapy platform
Rakuten Medical’s presentation at the J.P. Morgan Healthcare Conference 2026 delivered a clear message: the future of cancer care will …
-
JPM26: Boston Scientific acquires Penumbra in $14.5bn deal
Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech …
-
MedTech’s invisible enemy: The growing challenge of electromagnetic interference
Electromagnetic interference (EMI), which refers to the disturbance of a device’s performance by an unwanted electromagnetic field, is a serious …
